By G. Cameron Deemer – As COVID-19 spread across the nation, the healthcare industry quickly turned to technology to address pressing challenges, from how to make care accessible to caring for critically ill patients, all while protecting frontline workers from exposure to the virus.
Read More
We’ve rounded up some of the latest news and announcements pertaining to the coronavirus and the healthcare industry.
In this episode, hosts Daniel J. Marino and Shaillee J. Chopra speak with Doug McKinley to discuss how physicians can change their mindset around the “old normal” and pivot to align with the new normal that includes new telehealth environments, new rulings, new financial realities, and new healthcare systems.
By Nathaniel Arana – Physician Reimbursement and the Need for Independent Physician Groups to Assert Their Authority Against Payers. Years before COVID19, a physician I was speaking with asked me why insurance payers hardly ever cover Telehealth.
By David Shelton – The effects of COVID-19 on global health, economies and societies have been well documented and are nothing short of staggering. Millions of Americans face uncertain financial futures, which in turn creates uncertainty for organizations to whom consumers owe money.
By Carmen Heredia Rodriguez & Anna Almendrala – As a contact tracer, Teresa Ayala-Castillo is sometimes asked whether herbal teas and Vicks VapoRub can treat COVID-19. These therapies aren’t exactly official health guidance, but Ayala-Castillo isn’t fazed. She listens and then suggests other ideas — like getting rest and drinking plenty of fluids.
By Cameron Wood – Most physicians who have been practicing for a few decades remember the days when private payer reimbursements dwarfed Medicare reimbursements. That dynamic has long since flipped, starting with the 2008 recession.
The U.S. Department of Health and Human Services announced new Guidance that specifies what additional data must be reported to HHS by laboratories along with Coronavirus Disease 2019 (COVID-19) test results.
By JoNel Aleccia & Anna Maria Barry-Jester – “Save your business while saving lives,” reads the website of Because Health, a Seattle tech startup selling two types of tests to employers willing to pay $350 a pop to learn whether their workers have been infected with COVID-19.